{"id":9875,"date":"2021-05-18T10:28:27","date_gmt":"2021-05-18T17:28:27","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=9875"},"modified":"2021-05-19T10:29:20","modified_gmt":"2021-05-19T17:29:20","slug":"individuals-who-were-mildly-symptomatic-following-infection-with-sars-cov-2-b-1-1-28-have-neutralizing-antibodies-to-the-p-1-variant","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/05\/18\/individuals-who-were-mildly-symptomatic-following-infection-with-sars-cov-2-b-1-1-28-have-neutralizing-antibodies-to-the-p-1-variant\/","title":{"rendered":"Individuals Who Were Mildly Symptomatic Following Infection with SARS-CoV-2 B.1.1.28 Have Neutralizing Antibodies to the P.1 Variant"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><i><span style=\"font-weight: 400\">[Pre-print, not peer-reviewed]<\/span><\/i><span style=\"font-weight: 400\"> 84% of sera from to individuals (n=60) recovered from mild SARS-CoV-2 infection caused by the B.1.1.28 variant (the wild-type strain circulating in Brazil) had neutralizing antibodies against the P.1 variant of concern. Neutralization titers against the wild-type strain were consistently higher compared to the P.1 variant, but the differences were not more than a single dilution in over half of samples.<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Mendes-Correa et al.\u00a0(May 17, 2021). Individuals Who Were Mildly Symptomatic Following Infection with SARS-CoV-2 B.1.1.28 Have Neutralizing Antibodies to the P.1 Variant. Pre-print downloaded May 18 from <\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2021.05.11.21256908\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1101\/2021.05.11.21256908<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Pre-print, not peer-reviewed] 84% of sera from to individuals (n=60) recovered from mild SARS-CoV-2 infection caused by the B.1.1.28 variant (the wild-type strain circulating in Brazil) had neutralizing antibodies against the P.1 variant of concern. Neutralization titers against the wild-type strain were consistently higher compared to the P.1 variant, but the differences were not more&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/05\/18\/individuals-who-were-mildly-symptomatic-following-infection-with-sars-cov-2-b-1-1-28-have-neutralizing-antibodies-to-the-p-1-variant\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[67,201,32],"topic":[31],"class_list":["post-9875","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-antibodies","tag-immune-response","tag-immunity","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=9875"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9875\/revisions"}],"predecessor-version":[{"id":9876,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9875\/revisions\/9876"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=9875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=9875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=9875"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=9875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}